Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway

Inik Chang, Jan Liu, Shahana Majid, Sharanjot Saini, Mohd S. Zaman, Soichiro Yamamura, Varahram Shahryari, Takeshi Chiyomaru, Guoren Deng, Rajvir Dahiya, Yuichiro Tanaka

Research output: Contribution to journalArticle

Abstract

Long-term exposure to estrogen and its metabolites may play an important role in renal cell carcinogenesis. Catechol-O-methyltransferase (COMT) participates in the estrogen metabolism pathway by neutralizing toxic substances. Although reduced COMT activity has been suggested to be a risk factor for estrogen-associated cancers, no studies have investigated the biological significance of COMT in the pathogenesis of human renal cell cancers (RCCs). We initially found that COMT levels are significantly decreased in human RCC tissues and cells suggesting it plays a suppressive role in tumor development. However, transient overexpression of COMT has no functional effect on RCC cell lines. In contrast, when cells overexpressing COMT are treated with its substrate 4-hydroxyestradiol (4-OHE 2), growth is inhibited by apoptotic cell death. We also found that COMT overexpression combined with 4-OHE 2 induces upregulation of growth arrest- and DNA damage-inducible protein α (GADD45α). We further show that downregulation of GADD45α by a small interfering RNA-mediated approach inhibits cell death, indicating the essential role of GADD45α in the underlying mechanism of COMT action in response to 4-OHE 2. Finally, 4-methoxyestradiol fully reproduces the antiproliferative function of COMT with 4-OHE 2 by promoting GADD45α induction. Together, these findings show that COMT in the presence of 4-OHE 2 prevents RCC cell proliferation by enhancing apoptosis and that GADD45α plays a critical role in the COMT-mediated inhibition of RCC.

Original languageEnglish (US)
Pages (from-to)420-426
Number of pages7
JournalCarcinogenesis
Volume33
Issue number2
DOIs
StatePublished - Feb 8 2012
Externally publishedYes

Fingerprint

Catechol O-Methyltransferase
Renal Cell Carcinoma
Growth
Estrogens
4-hydroxyestradiol
Cell Death
Poisons
Small Interfering RNA
DNA Damage
Neoplasms
Carcinogenesis
Up-Regulation
Down-Regulation
Cell Proliferation

ASJC Scopus subject areas

  • Cancer Research

Cite this

Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. / Chang, Inik; Liu, Jan; Majid, Shahana; Saini, Sharanjot; Zaman, Mohd S.; Yamamura, Soichiro; Shahryari, Varahram; Chiyomaru, Takeshi; Deng, Guoren; Dahiya, Rajvir; Tanaka, Yuichiro.

In: Carcinogenesis, Vol. 33, No. 2, 08.02.2012, p. 420-426.

Research output: Contribution to journalArticle

Chang, I, Liu, J, Majid, S, Saini, S, Zaman, MS, Yamamura, S, Shahryari, V, Chiyomaru, T, Deng, G, Dahiya, R & Tanaka, Y 2012, 'Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway', Carcinogenesis, vol. 33, no. 2, pp. 420-426. https://doi.org/10.1093/carcin/bgr294
Chang, Inik ; Liu, Jan ; Majid, Shahana ; Saini, Sharanjot ; Zaman, Mohd S. ; Yamamura, Soichiro ; Shahryari, Varahram ; Chiyomaru, Takeshi ; Deng, Guoren ; Dahiya, Rajvir ; Tanaka, Yuichiro. / Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. In: Carcinogenesis. 2012 ; Vol. 33, No. 2. pp. 420-426.
@article{5b68e00e4f9648ba9ad5adc17a6db8a9,
title = "Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway",
abstract = "Long-term exposure to estrogen and its metabolites may play an important role in renal cell carcinogenesis. Catechol-O-methyltransferase (COMT) participates in the estrogen metabolism pathway by neutralizing toxic substances. Although reduced COMT activity has been suggested to be a risk factor for estrogen-associated cancers, no studies have investigated the biological significance of COMT in the pathogenesis of human renal cell cancers (RCCs). We initially found that COMT levels are significantly decreased in human RCC tissues and cells suggesting it plays a suppressive role in tumor development. However, transient overexpression of COMT has no functional effect on RCC cell lines. In contrast, when cells overexpressing COMT are treated with its substrate 4-hydroxyestradiol (4-OHE 2), growth is inhibited by apoptotic cell death. We also found that COMT overexpression combined with 4-OHE 2 induces upregulation of growth arrest- and DNA damage-inducible protein α (GADD45α). We further show that downregulation of GADD45α by a small interfering RNA-mediated approach inhibits cell death, indicating the essential role of GADD45α in the underlying mechanism of COMT action in response to 4-OHE 2. Finally, 4-methoxyestradiol fully reproduces the antiproliferative function of COMT with 4-OHE 2 by promoting GADD45α induction. Together, these findings show that COMT in the presence of 4-OHE 2 prevents RCC cell proliferation by enhancing apoptosis and that GADD45α plays a critical role in the COMT-mediated inhibition of RCC.",
author = "Inik Chang and Jan Liu and Shahana Majid and Sharanjot Saini and Zaman, {Mohd S.} and Soichiro Yamamura and Varahram Shahryari and Takeshi Chiyomaru and Guoren Deng and Rajvir Dahiya and Yuichiro Tanaka",
year = "2012",
month = "2",
day = "8",
doi = "10.1093/carcin/bgr294",
language = "English (US)",
volume = "33",
pages = "420--426",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway

AU - Chang, Inik

AU - Liu, Jan

AU - Majid, Shahana

AU - Saini, Sharanjot

AU - Zaman, Mohd S.

AU - Yamamura, Soichiro

AU - Shahryari, Varahram

AU - Chiyomaru, Takeshi

AU - Deng, Guoren

AU - Dahiya, Rajvir

AU - Tanaka, Yuichiro

PY - 2012/2/8

Y1 - 2012/2/8

N2 - Long-term exposure to estrogen and its metabolites may play an important role in renal cell carcinogenesis. Catechol-O-methyltransferase (COMT) participates in the estrogen metabolism pathway by neutralizing toxic substances. Although reduced COMT activity has been suggested to be a risk factor for estrogen-associated cancers, no studies have investigated the biological significance of COMT in the pathogenesis of human renal cell cancers (RCCs). We initially found that COMT levels are significantly decreased in human RCC tissues and cells suggesting it plays a suppressive role in tumor development. However, transient overexpression of COMT has no functional effect on RCC cell lines. In contrast, when cells overexpressing COMT are treated with its substrate 4-hydroxyestradiol (4-OHE 2), growth is inhibited by apoptotic cell death. We also found that COMT overexpression combined with 4-OHE 2 induces upregulation of growth arrest- and DNA damage-inducible protein α (GADD45α). We further show that downregulation of GADD45α by a small interfering RNA-mediated approach inhibits cell death, indicating the essential role of GADD45α in the underlying mechanism of COMT action in response to 4-OHE 2. Finally, 4-methoxyestradiol fully reproduces the antiproliferative function of COMT with 4-OHE 2 by promoting GADD45α induction. Together, these findings show that COMT in the presence of 4-OHE 2 prevents RCC cell proliferation by enhancing apoptosis and that GADD45α plays a critical role in the COMT-mediated inhibition of RCC.

AB - Long-term exposure to estrogen and its metabolites may play an important role in renal cell carcinogenesis. Catechol-O-methyltransferase (COMT) participates in the estrogen metabolism pathway by neutralizing toxic substances. Although reduced COMT activity has been suggested to be a risk factor for estrogen-associated cancers, no studies have investigated the biological significance of COMT in the pathogenesis of human renal cell cancers (RCCs). We initially found that COMT levels are significantly decreased in human RCC tissues and cells suggesting it plays a suppressive role in tumor development. However, transient overexpression of COMT has no functional effect on RCC cell lines. In contrast, when cells overexpressing COMT are treated with its substrate 4-hydroxyestradiol (4-OHE 2), growth is inhibited by apoptotic cell death. We also found that COMT overexpression combined with 4-OHE 2 induces upregulation of growth arrest- and DNA damage-inducible protein α (GADD45α). We further show that downregulation of GADD45α by a small interfering RNA-mediated approach inhibits cell death, indicating the essential role of GADD45α in the underlying mechanism of COMT action in response to 4-OHE 2. Finally, 4-methoxyestradiol fully reproduces the antiproliferative function of COMT with 4-OHE 2 by promoting GADD45α induction. Together, these findings show that COMT in the presence of 4-OHE 2 prevents RCC cell proliferation by enhancing apoptosis and that GADD45α plays a critical role in the COMT-mediated inhibition of RCC.

UR - http://www.scopus.com/inward/record.url?scp=84863034641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863034641&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgr294

DO - 10.1093/carcin/bgr294

M3 - Article

C2 - 22159223

AN - SCOPUS:84863034641

VL - 33

SP - 420

EP - 426

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 2

ER -